Remote ischemic conditioning prevents ischemic cerebrovascular events in children with moyamoya disease: a randomized controlled trial
Open Access
- 1 July 2024
- journal article
- research article
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 20 (9) , 925-934
Abstract
Background: Moyamoya disease (MMD) is a significant cause of childhood stroke and transient ischemic attacks (TIAs). This study aimed to assess the safety and efficacy of remote ischemic conditioning (RIC) in children with MMD. Methods: In a single-center pilot study, 46 MMD patients aged 4 to 14 years, with no history of reconstructive surgery, were randomly assigned to receive either RIC or sham RIC treatment twice daily for a year. The primary outcome measured was the cumulative incidence of major adverse cerebrovascular events (MACEs). Secondary outcomes included ischemic stroke, recurrent TIA, hemorrhagic stroke, revascularization rates, and clinical improvement assessed using the patient global impression of change (PGIC) scale during follow-up. RIC-related adverse events were also recorded, and cerebral hemodynamics were evaluated using transcranial Doppler. Results: All 46 patients completed the final follow-up (23 each in the RIC and sham RIC groups). No severe adverse events associated with RIC were observed. Kaplan–Meier analysis indicated a significant reduction in MACEs frequency after RIC treatment [log-rank test (Mantel–Cox), P = 0.021]. At 3-year follow-up, two (4.35%) patients had an ischemic stroke, four (8.70%) experienced TIAs, and two (4.35%) underwent revascularization as the qualifying MACEs. The clinical improvement rate in the RIC group was higher than the sham RIC group on the PGIC scale (65.2% vs. 26.1%, P < 0.01). No statistical difference in cerebral hemodynamics post-treatment was observed. Conclusions: RIC is a safe and effective adjunct therapy for asymptomatic children with MMD. This was largely due to the reduced incidence of ischemic cerebrovascular events. GraphicalKeywords
Funding Information
- The National Natural Science Foundation of China (No. 82371305)
This publication has 43 references indexed in Scilit:
- Transcranial Doppler in Childhood Moyamoya: An Underutilized Tool?Pediatric Neurology, 2023
- Chronic remote ischaemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis (the RICA trial): a multicentre, randomised, double-blind sham-controlled trial in ChinaThe Lancet Neurology, 2022
- Effect of Remote Ischemic Conditioning vs Usual Care on Neurologic Function in Patients With Acute Moderate Ischemic StrokeJAMA, 2022
- Remote ischemic conditioning for stroke: clinical data, challenges, and future directionsAnnals of Clinical and Translational Neurology, 2018
- Progress in moyamoya diseaseNeurosurgical Review, 2018
- Chronic Remote Ischemic Conditioning Is Cerebroprotective and Induces Vascular Remodeling in a VCID ModelTranslational Stroke Research, 2017
- Matched Cohort Analysis of the Effects of Limb Remote Ischemic Conditioning in Patients with Aneurysmal Subarachnoid HemorrhageTranslational Stroke Research, 2015
- Pediatric moyamoya disease: An analysis of 410 consecutive casesAnnals of Neurology, 2010
- Moyamoya Disease and Moyamoya SyndromeNew England Journal of Medicine, 2009
- Considerations in determining sample size for pilot studiesResearch in Nursing & Health, 2008